A Study of Renal Autologous Cell Therapy (REACT®) in Type 2 Diabetics With Chronic Kidney Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02836574 |
Recruitment Status :
Active, not recruiting
First Posted : July 19, 2016
Last Update Posted : February 15, 2022
|
Sponsor:
Prokidney
Collaborator:
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
Prokidney
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | May 2025 |
Estimated Study Completion Date : | May 2028 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):